Protein Labelling Market Size Worth USD 6.16 Billion By 2034 | CAGR: 8.47%
The global protein labelling market size is expected to reach USD 6.16 billion by 2034, according to a new study by Polaris Market Research. The report “Protein Labelling Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents, Kits, Services); By Method; By Application (Mass Spectrometry, Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Protein Microarray); By Region, And Segment Forecasts, 2026 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Recent developments in spin labels have expanded the capabilities of site-directed spin labeling of proteins, which in combination with electron paramagnetic resonance spectroscopy (SDSL-EPR). Private players and government agencies are also increasing their investments in proteomics and genomics R&D, with proteomics being the study of the entire protein content of a cell, tissue, or organism. Proteomic profiling approaches often require protein labeling methods before separation and analysis. For example, the United States National Institutes of Health (NIH) has allocated USD 37 billion to scientific research, which will likely drive further development in the field of protein labeling.
Cell-based assays are becoming increasingly popular in proteomics and genomics research as they provide information about intracellular molecular targets and can be performed in a biological context, unlike other techniques that analyze proteins outside of their natural environment. The increased funding for life sciences research has also led to the development of new and improved protein labeling techniques, which has further driven the market growth.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: Download Sample Report
The study of Post-translational Modification (PTM) of proteins is becoming increasingly popular in the fields of cell biology and disease treatment and prevention. Effective quantification methods of protein expression using tagging strategies such as iodoTMTzero Label Reagent have contributed to the efficient determination of PTMs. As a result, there has been a rise in PTM-related studies, which is driving the market. The market growth is also expected to be positively influenced by the emergence of novel techniques and the launch of improved products.
Use of fluorescent antibodies in combination with mass spectrometry has shown potential in the field of proteomics. This technique, known as immunoaffinity mass spectrometry, enables the specific isolation and quantification of target proteins from complex biological samples. The combination of these two powerful technologies has facilitated the identification of low-abundance proteins and post-translational modifications, leading to new insights in disease biology and drug discovery.
Protein Labelling Market Report Highlights
- North America dominated the global protein labeling market with 39.0% in 2025. The region growth is supported by strong biotechnology infrastructure, and extensive R&D investments.
- The Asia Pacific region is expected to witness the fastest growth witnessing 9.80% CAGR during 2026-2034, driven by growing demand for advanced molecular biology tools.
- The reagents segment accounted for the largest market share of 58.0% in 2025. The segment is driven by rising demand for advanced fluorescent and enzymatic labeling reagents.
- The immunological techniques segment accounted for significant revenue share of 21.0% share in 2025. This is due to growing use of protein labeling in antibody-based assays.
- Kits segment is expected to grow at a CAGR of 9.20% during 2026–2034 due to increasing use of protein labeling kits in super-resolution microscopy.
- Fluorescence microscopy segment is expected to register a CAGR of 8.60% during 2026–2034, driven by rising adoption of high-throughput fluorescence imaging in research applications.
- The global players include Thermo Fisher Scientific, Merck, Perkin Elmer, Promega Corporation, Roche, LGC Limited, New England Biolabs, LI-COR, GE Healthcare, and Jena Bioscience.
Polaris Market Research has segmented the protein labelling market report based on product, method, application, and region:
Protein Labelling, Product Outlook (Revenue - USD Billion, 2021 - 2034)
- Reagents
- Proteins
- Enzymes
- Probes/Tags
- Monoclonal Antibodies
- Other Reagents
- Kits
- Services
Protein Labelling, Method Outlook (Revenue - USD Billion, 2021 - 2034)
- In-vitro Labeling Methods
- Enzymatic Labeling
- Dye-based Labeling
- Co-translational Labeling
- Site-specific Labeling
- Nanoparticle Labeling
- Others
- In-vivo Labeling Methods
- Photoreactive Labeling
- Radioactive Labeling
- Others
Protein Labelling, Application Outlook (Revenue - USD Billion, 2021 - 2034)
- Cell-based Assays
- Fluorescence Microscopy
- Immunological Techniques
- Protein Microarray
- Mass Spectrometry
Protein Labelling, Regional Outlook (Revenue - USD Billion, 2021 - 2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Protein Labelling Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 2.97 billion |
| Market size value in 2026 | USD 3.22 billion |
| Revenue forecast in 2034 | USD 6.16 billion |
| CAGR | 8.47% from 2026 – 2034 |
| Base year | 2024 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered | By Product, By Method, By Application, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Key companies | Thermo Fisher Scientific, Merck, Perkin Elmer, Promega Corporation, Roche, LGC Limited, New England Biolabs, LI-COR, GE Healthcare, and Jena Bioscience |
| For Specific Research Requirements |
Source: Polaris Market Research Analysis
